NDC11 50458014030

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDC	Product root
50458-0140-30	50458-0140
50458-140-30	50458-140

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INVOKANA	CANAGLIFLOZIN	Janssen Pharmaceuticals, Inc.	b9057d3b-b104-4f09-8a61-c61ef9d4a3f3	2026-06-11	Warnings, Adverse reactions	Exact identifier ndc (package): 50458-140-30 ndc (product): 50458-140 ndc11 (package): 50458014030

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.